| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0955-1050-27 | 0955-1050 | HUMAN PRESCRIPTION DRUG | Sevelamer Carbonate | Sevelamer Carbonate | TABLET, FILM COATED | ORAL | 20180201 | N/A | NDA AUTHORIZED GENERIC | NDA022127 | Sanofi-Aventis U.S. LLC | SEVELAMER CARBONATE | 800 mg/1 | 270 TABLET, FILM COATED in 1 BOTTLE (0955-1050-27) |
| 58468-0133-1 | 58468-0133 | HUMAN PRESCRIPTION DRUG | Renvela | SEVELAMER CARBONATE | TABLET, FILM COATED | ORAL | 20230714 | N/A | NDA | NDA022127 | Genzyme Corporation | SEVELAMER CARBONATE | 800 mg/1 | 270 TABLET, FILM COATED in 1 BOTTLE (58468-0133-1) |
| 0955-1057-30 | 0955-1057 | HUMAN PRESCRIPTION DRUG | Sevelamer Carbonate | Sevelamer Carbonate | TABLET, FILM COATED | ORAL | 20230714 | N/A | NDA AUTHORIZED GENERIC | NDA022127 | Sanofi-Aventis U.S. LLC | SEVELAMER CARBONATE | 800 mg/1 | 270 TABLET, FILM COATED in 1 BOTTLE (0955-1057-30) |